High expression of RUNX1‐ETO9a was detected in a proportion of (86 out of 118) paediatric and adult t(8;21) AML which correlated with poor clinical outcome and increased c‐KIT expression.31 This evidence concerns the gene RUNX1 and acute myeloid leukemia.